Oligonucleotide-based gene therapy for cardiovascular disease.
about
STAT3 inhibitors for cancer therapy: Have all roads been explored?Encapsulation of NF-kappaB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered releaseTransforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation
P2860
Oligonucleotide-based gene therapy for cardiovascular disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Oligonucleotide-based gene therapy for cardiovascular disease.
@en
type
label
Oligonucleotide-based gene therapy for cardiovascular disease.
@en
prefLabel
Oligonucleotide-based gene therapy for cardiovascular disease.
@en
P2093
P2860
P356
P1476
Oligonucleotide-based gene therapy for cardiovascular disease.
@en
P2093
A Moriguchi
H Matsushita
K Matsumoto
K Yamamoto
R Morishita
Y Taniyama
P2860
P304
P356
10.1515/CCLM.1998.090
P577
1998-08-01T00:00:00Z